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locus do TCF7L2 com diabetes tipo 2 em indivíduos brasileiros
Gustavo Barcelos Barra1,2, Ludmila Alves Sanches Dutra1, Sílvia Conde 
Watanabe3,4, Patrícia Godoy Garcia Costa1, Patrícia Sales Marques 
da Cruz3, Monalisa Ferreira Azevedo2,3, Angélica Amorim Amato2,3,4
ABSTRACT
Objective: To investigate the association of the T allele of the single nucleotide polymorphism 
(SNP) rs7903146 of TCF7L2 with the occurrence of T2D in a sample of subjects followed up at 
the Brasilia University Hospital. Subjects and methods: The SNP rs7903146 of TCF7L2 was 
genotyped by allele-specific PCR in 113 patients with known T2D and in 139 non-diabetic con-
trols in Brasilia, Brazil. Results: We found that the T allele of the SNP rs7903146 of TCF7L2 was 
significantly associated with T2D risk (odds ratio of 3.92 for genotype TT in the recessive genetic 
model, p = 0.004 and 1.5 for T allele, p = 0.032). Conclusion: These results reinforce previous 
findings on the consistent association of this genetic factor and the risk of T2D in populations of 
diverse ethnic backgrounds. Arq Bras Endocrinol Metab. 2012;56(8):479-84
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RESUMO
Objetivo: Investigar a associação do alelo T do polimorfismo de nucleotídeo único (SNP) 
rs7903146 do TCF7L2 com a ocorrência de DM2 em uma amostra de indivíduos acompanha-
dos no Hospital Universitário de Brasília. Sujeitos e métodos: O SNP 7903146 do TCF7L2 foi 
genotipado por PCR alelo-específica em 113 pacientes portadores de DM2 e em 139 controles 
não diabéticos em Brasília, Brasil. Resultados: Foi observada associação significativa do alelo 
T do SNP rs7903146 do TCF7L2 com a ocorrência de DM2 (razão de chances de 3,92 para o ge-
nótipo TT utilizando o modelo genético recessivo, p = 0,003; e de 1,5 para o alelo T, p = 0,032). 
Conclusão: Esse resultado reforça os achados prévios de associação consistente desse fator 
genético com o risco de diabetes em populações de origens étnicas diversas. Arq Bras Endocrinol 
Metab. 2012;56(8):479-84
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INTRODUCTION
Type 2 diabetes (T2D) is a heterogeneous group of metabolic disorders characterized by the inability 
of pancreatic beta cells to increase insulin secretion in 
order to compensate for insulin resistance (1). It repre-
sents a significant worldwide burden due to the alarm-
ing increase in its incidence over the last decades (2,3), 
and because of its significant morbidity and mortality 
rates (4). 
Environment and lifestyle changes are believed to 
play a primary role in the current epidemic of T2D, 
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attributed to complex genetic factors. There is com-
pelling evidence that genetic susceptibility to the dis-
ease is polygenic, and genome-wide association studies 
have thus far identified almost 50 loci associated with 
T2D risk (5-8). Many of the genetic variants identi-
fied to date have been associated with small effect sizes, 
although single nucleotide polymorphisms (SNP) at 
the transcription factor 7-like 2 gene (TCF7L2) locus 
on chromosome 10q have been strongly and consis-
tently associated with T2D risk in various populations 
and ethnic groups (6,9-11). An intronic SNP at this 
locus in particular, rs7903146, is considered the most 
important known genetic risk factor for T2D develop-
ment (10).
TCF7L2 encodes the transcription factor TCF7L2, 
involved in the Wnt signaling pathway, which seems to 
be critical to pancreatic islet development and adipo-
genesis (12). TCF7L2 forms heterodimers with beta-
catenin to induce the expression of various genes, in-
cluding the gene encoding the insulinotropic hormone 
glucagon-like peptide 1 (13), the insulin gene (14), 
and genes that encode proteins involved in process-
ing and exocytosis of insulin granules (15). Although 
the mechanisms underlying the association of TCF7L2 
polymorphisms and alterations in glucose homeostasis 
are not clear, these data suggest that this transcription 
factor primarily affects insulin secretion. TCF7L2 poly-
morphisms seem to influence beta cell function (6,16-
19) and insulin sensitivity (20-22).
Although disease association studies have shown 
that the T allele of the rs7903146 SNP at the TCF7L2 
locus is strongly associated with T2D risk in diverse 
ethnic groups, it is noteworthy that the frequency of 
SNPs at this locus was shown to be different in the va-
rious populations included in these studies. The T allele 
of rs7903146 SNP at the TCF7L2 was seen in 18-42% 
of non-diabetic European and Arab populations (23-
25), but in less than 5% of healthy individuals in studies 
with Southeast Asian populations (26,27). These data 
might suggest that the effect size of this SNP on T2D 
risk may vary among populations worldwide.
Marquezine and cols. reported that the T allele 
of rs7903146 SNP at the TCF7L2 locus is associated 
with a 1.57 increase in the risk of T2D in a sample of 
patients with documented multivessel coronary artery 
disease from the multivessel coronary disease patient 
studies (MASS II Study) in Southeastern Brazil, al-
though this genetic variant did not increase the accu-
racy of a validated diabetes risk prediction score for the 
Brazilian population (28). We have previously shown 
a 37% frequency of the T allele of rs7903146 SNP at 
the TCF7L2 locus in a group of 104 healthy young 
volunteers (mean age of 27.7 ± 11 years) randomly 
selected in Brasilia, the capital of Brazil (29). The Bra-
zilian population represents a heterogeneous ethnic 
group, and Brasilia is a relatively young city; its popula-
tion comprises individuals from almost all regions of 
the country. In this study, we describe the frequency of 
the alleles of the rs7903146 SNP at the TCF7L2 locus, 
and the association between the T allele of this poly-
morphism and the occurrence of T2D in a small sample 




A total of 252 subjects were enrolled in this study, all 
from population seen at the Brasilia University Hos-
pital, Brasilia, Brazil. The patients (113) were not re-
lated, aged over 40 years, and had been diagnosed with 
T2D after the age of 30 years, in accordance with 2006 
American Diabetes Association (ADA) (30); individuals 
with features suggestive of other types of diabetes were 
excluded from the study. Control subjects (139) with 
normal glucose tolerance were also not related, aged 
over 40 years, and were seen for disorders not related 
to diabetes mellitus at the Brasilia University Hospital. 
Written informed consent was obtained from each par-
ticipant after a full explanation of the study, which was 
approved by the Ethics Committee of the Health Sci-
ences School from the University of Brasilia.
Clinical and biochemical data
The following clinical and biochemical data were ob-
tained from the medical records of diabetic patients: 
family history of T2D, personal history of hyperten-
sion, dyslipidemia, hyperuricemia, nonalcoholic fatty 
liver disease, microvascular chronic complications (ne-
phropathy, retinopathy, and neuropathy), smoking 
status (previous and current), presence of acantosis ni-
gricans, body mass index (weight in kg/height in m2), 
waist circumference, fasting and postprandial blood 
glucose, serum lipid profile, serum urea, creatinine, uric 
acid, and liver enzymes. Complete information was not 
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rs7903146  genotyping 
A venous blood sample (5 mL) was obtained by pe-
ripheral venipuncture using disposable material and 
EDTA-containing tubes from each patient. All samples 
were collected at the Brasilia University Hospital. DNA 
was extracted by the Chelex-100 method (31), and 
rs7903146  genotype assays were conducted by allele-
specific polymerase chain reaction. The primers and 
conditions for this reaction have been described else-
where (29).
Statistical analyses 
Categorical data were described in terms of absolute 
and relative frequencies, and were analyzed using 
Fisher’s exact test. Numerical data were expressed as 
means ± standard deviations. Hardy-Weinberg equi-
librium and the association between disease status and 
the genetic variant were tested by Pearson’s c2 test, 
which was also used to find the best genetic model 
of inheritance that described effect of the rs7903146 
SNP at the TCF7L2 locus. Odds Ratios, 95% confi-
dence intervals (95%CI), and all statistical tests were 
carried out using GraphPad Prism version 5.00 for 
Windows, GraphPad Software, San Diego, California, 
USA (www.graphpad.com). A p value < 0.05 was con-
sidered statistically significant. 
RESULTS
Mean age of patients was 58.6 ± 9.8 years, and 76.9% 
were female. In the control group, mean age was 56.5 
± 9.9 years, and the majority was also female (84.1%). 
Mean age (p = 0.063) and gender distribution were 
similar (c2 = 2.08, df = 1, p = 0.14) in both groups. De-
mographic, clinical, and biochemical parameters from 
T2D patients are described in table 1. 
Allele and genotype frequencies of the rs7903146 
SNP at TCF7L2 are summarized in table 2. Deviation 
from the Hardy-Weinberg equilibrium was not seen in 
either T2D (c2 = 3.14, df = 1, p = 0.08), or the control 
group (c2 = 1.03, df = 1, p = 0.31). Association analyses, 
which were performed using the chi-square test with 
2 degrees of freedom, yielded a significant association 
between rs7903146 SNP of TCF7L2 and disease sus-
ceptibility (c2 = 8,7, df = 2, p = 0.012). To investigate 
in which model the effect of rs7903146 SNP at the 
TCF7L2 would fit, dominant, recessive, and co-domi-
nant genetic models were considered (Table 2). Analy-
Table 1. Clinical and biochemical characteristics of T2D patients
Characteristics of T2D patients Mean ± SD n
Age (years) 58.6 ± 9.8 113
Gender (female) 76.9 113
Current smoking (%) 7.9 89
Previous smoking (%) 40.0 80
Family history of diabetes (%) 79.3 87
Acanthosis nigricans (%) 42.5 73
Hypertension (%) 78.8 85
Dyslipidemia (%) 77.2 79
Hyperuricemia (%) 30.2 63
Hepatic steatosis (%) 3.7 54
Diabetic nephropathy (%) 35.3 68
Diabetic retinopathy (%) 21.2 66
Diabetic neuropathy (%) 26.6 79
Body mass index (kg/m2) 29.1 ± 4.9 78
Waist circumference (cm) 100.7 ± 11.3 47
Fasting glucose (mg/dL) 147.6 ± 59.5 66
Postprandial glucose (mg/dL) 209.2 ± 108.7 36
Total cholesterol (mg/dL) 203.4 ± 56.9 62
HDL cholesterol (mg/dL) 42.3 ± 13.9 62
LDL cholesterol (mg/dL) 118.2 ± 43,1 62
Triglycerides (mg/dL) 217 ± 156.6 62
Urea (mg/dL) 36.8 ± 13.2 61
Creatinine (mg/dL) 0.85 ± 0.26 61
Uric acid (mg/dL) 5.4 ± 1.3 43
Alanine aminotransferase (U/L) 22.6 ± 8.7 56
Aspartate aminotransferase (U/L) 23.39 ± 10.2 56
n: total number of patients with data retrieved from hospital records; SD: standard deviation.
sis performed in the recessive genetic model, with two 
copies of T being required for increased risk, yielded 
the strongest association between rs7903146 and T2D 
(c2 = 8.64, df = 1, p = 0.003; Table 2). No significant 
associations were observed in the dominant (c2 = 1.22, 
df = 1, p = 0.26) and co-dominant (c2 = 0.35, df = 1, p 
= 0.55) model of inheritance. Chi-square statistics also 
indicated a significant association between the TT gen-
otype and T2D compared with the CC reference geno-
type (c2 = 8.3; df = 1; p = 0.004), and yielded an odds 
ratio of 4.04 (95% CI; 1.48-11.0). The same analysis 
was carried out for heterozygotes, and it showed that 
the CT genotype was not significantly associated with 
T2D (c2 = 0.06, df = 1, p = 0.81), yielding an odds ratio 
of 1.07 (95% CI; 0.63-1.80). Moreover, allelic odds 
ratio of rs7903146 T carriers was 1.51 (95% CI; 1.03-
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DISCUSSION
The identification of genetic variants influencing T2D 
is a major focus of research to improve the understand-
ing of the mechanisms underlying the pathogenesis of 
this disorder. Recent advances, such as the develop-
ment of genome-wide association studies have enabled 
the identification of a number of genes associated with 
T2D risk. In this scenario, common genetic variants in 
TCF7L2 gene were recently associated with T2D risk 
by Grant and cols. (9), and these findings were con-
sistently reproduced in various populations (6,10,11). 
Since then, TCF7L2 has been considered one of the 
most important known genetic risk factors for the de-
velopment of the disease.
In this study, the association of the rs7903146 poly-
morphism at the TCF7L2 and diabetes risk was found 
in a small sample from the population of Brasilia, in 
the Central Western region of Brazil. The odds ratio 
for the association with genotype TT (recessive model) 
were 3.92 (CI 95%; 1.49-10.3); and for T allele 1.51 
(CI 95%; 1.03-2.21), similar to that reported in the 
previous study involving the Brazilian population (28), 
as well as in other populations (10,25,32). The T allele 
was significantly more frequent in T2D patients than in 
controls (35.8% versus 27%; p = 0.032). The frequency 
of the risk allele in the control group was similar to 
Table 2. Genotypes, alleles, and statistical data of rs7903146 SNP at the TCF7L2 in diabetic and control subjects
Genotype distribution
  CC CT TT Total
T2D 49 (43.4%) 47 (41.6%) 17 (15%) 113
Controls 70 (50.4%) 63 (45.6%) 6 (4.3%) 139
Total 119 110 23 252
Allelic distribution
  C T Total
T2D 145 (64.2%) 81 (35.8%) 226
Controls 203 (73%) 75 (27%) 278
Total 348 156 504
Genetic models and statistical data
Genetic Model Odds ratio (95% CI) Chi-square Degrees of freedom P
Association (CC vs. CT vs. TT) 8.70 2 0.012
Dominant (CT + TT vs. CC) 1.32 (0.80-2.18) 1.22 1 0.260
Recessive (TT vs. CT + CC) 3.92 (1.49-10.3) 8.64 1 0.003
Co-dominant (CT vs. CC + TT) 1.16 (0.70-1.92) 0.35 1 0.55
Homozigote (CC vs. TT) 4.04 (1.48-11.0) 8.30 1 0.004
Heterozigote (CC vs. CT) 1.06 (0.63-1.80) 0.06 1 0.81
Allele (C vs. T) 1.51 (1.03-2.21) 4.58 1 0.032
that described in non-diabetic European (Cauchi, 2006 
and Gonzalez, 2008) and Arab (Ezzidi, 2009) popula-
tions, and higher than that reported in Southeast Asian 
populations, in which this variant occurs in less than 5% 
of the general population (Chang, 2007; Wen, 2010). 
The frequency of the T allele of rs7903146 SNP 
at the TCF7L2 in both T2D and control subjects was 
lower than our previously reported frequency (37%). 
The difference in the mean age of subjects enrolled in 
each study (27.7 ± 11 versus 58.6 ± 9.8 and 56.5 ± 9.9 
years in T2D and controls, respectively), and it is be 
possible that the subjects enrolled in the first study may 
be representative of a group at higher risk of develop-
ing T2D with advancing age, since the frequency of the 
T allele in this group was more similar than that found 
in T2D patients in this study.
Despite the strong association between rs7903146 
polymorphism at the TCF7L2 and T2D risk in clini-
cal studies, it is not readily apparent how this intronic 
TCF7L2 variant increases susceptibility to the disease. 
There is evidence that TCF7L2 has an important role 
in maintaining beta cell mass and function. This tran-
scription factor itself seems to be critical for beta cell 
proliferation, protection against apoptosis, and insulin 
secretion (14,33). In addition, it has been shown to be 
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and gastric inhibitory peptide receptors in beta cells, 
which mediate the effects of the correspondent incretin 
hormones to promote beta cell proliferation, neogen-
esis, and survival in rodent models (34). More recently, 
TCF7L2 expression in the endocrine pancreas was cor-
related not only with beta cell proliferation, but also 
with beta cell regeneration in different murine models 
of diabetes (35). In the same study, it was shown that in 
human exocrine pancreatic tissue, TCF7L2 overexpres-
sion induced beta cell phenotype and insulin produc-
tion in ductal epithelial cells (35).
Our results confirm the previous findings from 
Marquezine and cols. (28), who studied a population 
from a different region of Brazil. Replication of the as-
sociation of this genetic variant with T2D risk in a small 
Brazilian sample reinforces the strength of this associa-
tion in our population and worldwide. However, it is 
important to point out that in spite of all the efforts to 
understand how the T allele of SNP rs7903146 at the 
TCF7L2 is precisely related to T2D risk, clinical stud-
ies have failed to show that determination of TCF7L2 
genotype adds to clinical criteria in determining the 
individual risk of the disease. Hence, although it is be-
lieved that knowledge of genetic factors associated with 
T2D risk has the potential to bring new perspectives 
to the development of more effective preventative and 
therapeutic strategies for the disease, there is a lot to be 
understood before this information can be translated 
into benefits in clinical practice. 
Disclosure: no potential conflict of interest relevant to this article 
was reported. 
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